JPH07222798A - Transfusion set and medicinal liquid injecting device using the same - Google Patents

Transfusion set and medicinal liquid injecting device using the same

Info

Publication number
JPH07222798A
JPH07222798A JP5179888A JP17988893A JPH07222798A JP H07222798 A JPH07222798 A JP H07222798A JP 5179888 A JP5179888 A JP 5179888A JP 17988893 A JP17988893 A JP 17988893A JP H07222798 A JPH07222798 A JP H07222798A
Authority
JP
Japan
Prior art keywords
balloon
medicinal liquid
infusion set
solution
chemical liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5179888A
Other languages
Japanese (ja)
Other versions
JP2725557B2 (en
Inventor
Shoji Kawamoto
昇司 川本
Morihiro Okuda
守宏 奥田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP5179888A priority Critical patent/JP2725557B2/en
Publication of JPH07222798A publication Critical patent/JPH07222798A/en
Application granted granted Critical
Publication of JP2725557B2 publication Critical patent/JP2725557B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/148Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
    • A61M5/152Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags pressurised by contraction of elastic reservoirs

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

PURPOSE:To inject a medicinal liquid at a specified speed into a human body by providing a medicinal liquid flow tube with an opening/closing means and a flow rate control part for controlling a medicinal liquid injection rate. CONSTITUTION:This transfusion set is composed of a balloon part (a) and the medicinal liquid flow tube (b). The balloon part (a) has a balloon 1 of a flat shape into which the medicinal liquid is housed to a pressurized state. This balloon 1 has a medicinal liquid outflow port 3 and a medicinal liquid inflow port 4 on its opposite sides. The medicinal liquid inflow port 4 is provided with a plug body consisting of a rubber-like elastic material for inflow of the medicinal liquid into the lumen and is so formed that the medicinal liquid is injected by pricking of the pricking needle of an injector. The medicinal liquid outflow port 3 consists of a flexible tube. A breaking member which is the rigid opening/closing means 11 having a brittle site is inserted therein. The medicinal liquid flowing out of the balloon 1 is injected into the human body from the pricking needle or catheter connected to a connecting means 8 via the flow rate control section 5.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は所定量の薬液を体内に注
入するための輸液セットおよびそれを使用した薬液注入
器具に関し、更に詳しくは、バル−ン内に加圧状態で貯
蔵された薬液を、一定速度で患者に注入することができ
る輸液セットおよびそれを使用した薬液注入器具に関す
る。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an infusion set for injecting a prescribed amount of medicinal solution into the body and a medicinal solution injecting device using the same, and more particularly, a medicinal solution stored under pressure in a balloon. The present invention relates to an infusion set capable of injecting into a patient at a constant rate and a drug solution injecting device using the same.

【0002】[0002]

【従来の技術】従来、バッグ内に収容された薬液を人体
に注入する際には、ベッドに横たわった患者に、ヘッド
差を利用してロ−ラクランプで薬液注入速度を調節しな
がら行ってきた。近年、抗生物質、抗ガン剤、麻酔剤等
の薬液を血管、膀胱等に10時間以上かけて少しずつ注入
する必要がでてき、歩行携帯型の輸液セットの開発が要
請されてきた。かかる要請に応えた輸液セットとして、
弾性材料からなるバル−ンに薬液を収納し、バル−ンの
収縮力を利用して薬液を人体に持続注入する器具(特開
平4-67873号公報)が知られている。該公報に記載され
た輸液セットを図6および図7に示す。図6は該輸液セ
ットの全体説明図であって、穿刺針がハウジングの栓体
に穿刺していない状態を示しており、図7は図6に示す
ハウジングのバル−ンに薬液を充填した時の状態を示す
拡大断面図である。図6および図7の輸液セットは、バ
ル−ン42を収納するハウジング43からなるバル−ン部e
と、薬液の流量を調節するための流量制御部44を有する
薬液流通チュ−ブ部fとからなっている。バル−ン42は
図7に示す棒状内軸45と、該内軸45に滑動自在に外装さ
れてなる円筒状外軸46と、前記内軸45の一端であって外
軸46が外装される側と反対側の端部に内軸と一体に形成
された内軸受け47と、前記内軸45および外軸46を被覆す
るようにこれら両軸の外部に設けられ、その一端が内軸
45に密着固定され、他端が外軸46に密着固定された弾性
材料製バル−ン42とからなっている。またハウジング43
の一端には薬液流出入部であるアダプタ−48が形成さ
れ、内軸45の内部を介して薬液通路51と連通している。
薬液通路51の端部には栓体49が設置され、バル−ン42内
部への薬液流入時には注射針50で薬液を注入し、バル−
ン42からの薬液流出時には図6の注射針50が栓体49を穿
刺することによって、薬液は薬液流通チュ−ブ部f端部
の接続具52に設けられた穿刺針(図示せず)から人体に
注入される構造をしている。
2. Description of the Related Art Conventionally, when injecting a drug solution contained in a bag into a human body, a patient lying on a bed has been controlled while adjusting a drug solution injecting rate by a roller clamp using a head difference. . In recent years, it has become necessary to gradually inject liquid medicines such as antibiotics, anti-cancer agents, and anesthetics into blood vessels, bladders, etc. over 10 hours or more, and development of a portable ambulatory infusion set has been demanded. As an infusion set in response to such a request,
There is known a device (Japanese Patent Laid-Open No. 4-67873) in which a drug solution is contained in a balloon made of an elastic material and the contraction force of the balloon is used to continuously inject the drug solution into the human body. The infusion set described in this publication is shown in FIGS. 6 and 7. FIG. 6 is an overall explanatory view of the infusion set, showing a state in which the puncture needle has not punctured the plug body of the housing, and FIG. 7 shows when the balloon of the housing shown in FIG. 6 is filled with the drug solution. It is an expanded sectional view showing the state. The infusion set shown in FIGS. 6 and 7 has a balloon portion e formed of a housing 43 that houses the balloon 42.
And a chemical liquid flow tube section f having a flow rate control unit 44 for adjusting the flow rate of the chemical liquid. The balloon 42 has a rod-shaped inner shaft 45 shown in FIG. 7, a cylindrical outer shaft 46 slidably mounted on the inner shaft 45, and an outer shaft 46 which is one end of the inner shaft 45. Side inner side bearing 47 formed integrally with the inner shaft at the end opposite to the inner side, and the inner shaft 45 and the outer shaft 46 are provided outside these shafts so as to cover them, and one end thereof is the inner shaft.
A balloon 42 made of an elastic material is closely fixed to 45 and the other end is closely fixed to the outer shaft 46. Also housing 43
An adapter-48, which is a chemical liquid inflow / outflow portion, is formed at one end of the inner side of the inner surface of the inner shaft 45 and communicates with the liquid chemical passage 51 through the inside of the inner shaft 45.
A stopper 49 is installed at the end of the drug solution passage 51, and when the drug solution flows into the balloon 42, the drug solution is injected by an injection needle 50 to
6 punctures the stopper 49 when the drug solution flows out from the inlet 42, the drug solution is supplied from a puncture needle (not shown) provided in the connector 52 at the end of the drug solution flow tube part f. It has a structure that is injected into the human body.

【0003】[0003]

【発明が解決しょうとする課題】かかる輸液セットは、
バル−ンが大きな変形をしないで一定圧力で薬液を流出
させるために、バル−ン内部に内軸と外軸を設けバル−
ンが長軸方向の中心軸に沿って変形するようにし、更に
バル−ン内部の端部に内軸受けを設けることによってバ
ル−ンがハウジングの内壁に沿って変形する構造をして
いる。しかしながら、かかる輸液セットはバル−ン内部
にかかる機構を設けているためにハウジングの小型化が
自ずから限定され、患者が携行しながら薬液を注入する
際に問題があった。また、この輸液セットは薬液流通チ
ュ−ブの端部に設置された穿刺針をバル−ンと接続して
薬液を人体に注入する機構であるので、バル−ンと薬液
流通チュ−ブとを別々に管理するために、衛生上だけで
なく人体への薬液注入速度の調節でも困難があった。更
に、この輸液セットはバル−ンの内圧だけで薬液を流出
させるので、バル−ン内の薬液が少なくなると、バル−
ン内圧が低下したとき薬液の流出速度が低下する問題が
あった。本発明者等はかかる問題を解決するために鋭意
研究した結果、従来使用時にバル−ンと薬液流通チュ−
ブとを接続して人体に薬液を注入していた輸液セット
を、予めバル−ンと薬液流通チュ−ブとを一体化した輸
液セットとして使用することによって、本発明の課題が
解決されることを見出し本発明に到達した。また、本発
明は薬液を充填したバル−ンの収縮力だけで薬液を人体
へ一定の注入速度で注入が困難な場合には、薬液を充填
したバル−ンの圧力よりも高い圧力をバル−ンに加える
機構を設けることによって、簡単な機構で薬液を人体に
注入できる薬液注入器具である。
[Problems to be Solved by the Invention]
The inner and outer shafts are provided inside the balun to allow the chemical solution to flow out at a constant pressure without significant deformation of the balun.
The valve is deformed along the central axis in the long axis direction, and an inner bearing is provided at the end of the inside of the ball so that the ball is deformed along the inner wall of the housing. However, since such an infusion set is provided with such a mechanism inside the balloon, miniaturization of the housing is naturally limited, and there is a problem in injecting the drug solution while the patient carries it. Further, since this infusion set is a mechanism for connecting the puncture needle installed at the end of the drug solution distribution tube to the balloon and injecting the drug solution into the human body, the valve and the drug solution distribution tube are connected to each other. Since they are managed separately, it is difficult not only for hygiene but also for adjusting the rate of injecting the drug solution into the human body. Furthermore, since this infusion set allows the chemical solution to flow out only by the internal pressure of the balloon, when the chemical solution in the balloon becomes low,
There has been a problem that the outflow rate of the chemical liquid decreases when the internal pressure of the liquid decreases. The inventors of the present invention have conducted extensive studies to solve such problems, and as a result, have found that the balloon and the chemical liquid distribution tube during the conventional use.
The problem of the present invention can be solved by using an infusion set that has been connected to a tube and injecting a medicinal solution into a human body as an infusion set in which a balloon and a medicinal solution circulation tube are integrated in advance. And has reached the present invention. Further, according to the present invention, when it is difficult to inject the liquid medicine into the human body at a constant infusion rate only by the contraction force of the balloon filled with the liquid medicine, a pressure higher than the pressure of the balloon filled with the liquid medicine is applied. This is a drug solution injector that can inject a drug solution into a human body with a simple mechanism by providing a mechanism for adding the drug solution to the human body.

【0004】[0004]

【課題を解決するための手段】すなわち、本発明は加圧
状態で薬液を貯蔵し、かつ薬液を流入させるための薬液
流入口と薬液を流出させるための薬液流出口とを有する
バル−ンと、該薬液流出口から延びた薬液流通チュ−ブ
とからなる輸液セットにおいて、前記薬液流通チュ−ブ
に薬液を流通または閉止するための開閉具と、薬液注入
速度を制御するための流量制御部、および注射針または
カテ−テルと接続するための接続具が設けられてなる輸
液セットである。
That is, the present invention relates to a balloon having a chemical liquid inlet for storing a chemical liquid under pressure and having a chemical liquid flow in and a chemical liquid flow outlet for letting a chemical liquid flow out. In a transfusion set comprising a chemical liquid flow tube extending from the chemical liquid flow outlet, an opening / closing tool for flowing or closing the chemical liquid in the chemical liquid flow tube, and a flow rate control unit for controlling the chemical liquid injection speed. , And an injection needle or a connector for connecting with a catheter.

【0005】また、本発明は前記輸液セットにおいて、
開閉具が破断部材または三方活栓からなる輸液セットで
ある。更に、本発明は前記輸液セットにおいて、 バル
−ン材料が弾性ゴムまたは熱可塑性樹脂からなる輸液セ
ットである。更にまた、本発明は前記輸液セットにおい
て、流量制御部の薬液上流側に定量弁が設けられてなる
輸液セットである。また、本発明は前記輸液セットにお
いて、定量弁が内径が変形可能な弁孔を有するゴム状弾
性体からなるオリフイス体と、該弁孔の内径を調整する
ための調整手段とからなる輸液セットである。更に、本
発明は前記輸液セットにおいて、バル−ンが扁平形状を
している輸液セットである。更にまた、本発明は前記輸
液セットにおいて、ハウジング内に輸液セットのバル−
ンと、薬液を充填したバル−ンの圧力より高い圧力で前
記バル−ンを加圧する加圧機構が収容されてなる薬液注
入器具である。また、本発明は前記薬液注入器具におい
て、加圧機構がバネまたは加圧ガスを使用してなる薬液
注入器具である。
The present invention also provides the above-mentioned infusion set,
It is an infusion set in which the opening / closing tool comprises a breaking member or a three-way stopcock. Further, the present invention is the above-mentioned infusion set, wherein the balloon material is made of elastic rubber or thermoplastic resin. Furthermore, the present invention is the above-mentioned infusion set, wherein a metering valve is provided on the upstream side of the drug solution in the flow rate control unit. Further, the present invention provides the infusion set, wherein the metering valve comprises an orifice body made of a rubber-like elastic body having a valve hole whose inner diameter is deformable, and an adjusting means for adjusting the inner diameter of the valve hole. is there. Furthermore, the present invention is the above-mentioned infusion set, wherein the balloon has a flat shape. Furthermore, the present invention provides the infusion set as described above, wherein the infusion set has a valve inside the housing.
And a pressurizing mechanism for pressurizing the balloon at a pressure higher than the pressure of the balloon filled with the chemical liquid. Further, the present invention is the above-mentioned chemical liquid injector, wherein the pressurizing mechanism uses a spring or a pressurized gas.

【0006】[0006]

【作用】本発明輸液セットは薬液流入口からバル−ン内
に薬液を充填することによってバル−ン内を加圧状態に
した後、薬液流通チュ−ブに設置された開閉具を開くこ
とによって、バル−ン内の薬液はバル−ンの薬液流出口
から薬液流通チュ−ブ内へ流れ、流量制御部によって人
体への注入速度が一定に制御されながら、接続具に接続
された穿刺針またはカテ−テルから人体に薬液が人体に
注入される。また、本発明は前記輸液セットにおいて、
薬液をバル−ン内に充填して膨張したバル−ンの外側か
ら、該バル−ンの圧力より大きい圧力機構でバル−ンを
圧縮することによって、バル−ン内の薬液は薬液流通チ
ュ−ブに設置された流量制御部を経て一定の注入速度に
制御されながら患者に注入される。
According to the infusion set of the present invention, the inside of the balloon is pressurized by filling the inside of the balloon with the medicine from the medicine inlet, and then the opening / closing tool installed in the medicine circulating tube is opened. , The drug solution in the balloon flows from the drug solution outlet of the balloon into the drug solution flow tube, and while the injection rate into the human body is controlled to be constant by the flow rate control unit, the puncture needle connected to the connector or A medical fluid is injected into the human body from the catheter. The present invention also provides the infusion set,
By compressing the balloon from the outside of the balloon which is filled with the chemical liquid and expanded by the pressure mechanism larger than the pressure of the balloon, the chemical liquid in the balloon is supplied with the chemical liquid. It is infused into the patient while being controlled at a constant infusion rate via a flow rate control unit installed in the chamber.

【0007】[0007]

【実施例】以下実施例で本発明の輸液セットおよびそれ
を使用した薬液注入器具の一例を説明する。図1は本発
明の輸液セットの一実施例の説明図、図2は図1のバル
−ンに薬液を充填したときのバル−ン部の拡大断面図、
図3は流量制御部の薬液上流側チュ−ブに定量弁を配設
した流量制御部付近の説明図、図4は本発明の輸液セッ
トを使用した薬液注入器具のバル−ン部の拡大断面図、
図5は本発明の輸液セットを使用した薬液注入器具の他
の実施例を示す薬液注入器具のバル−ン部の拡大断面
図、図6は特開平4-67873号公報に記載されている薬液
注入器具の全体説明図、図7は図6に示すハウジングの
バル−ンに薬液を充填した時の状態を示す拡大断面図で
ある。
EXAMPLES Examples of the infusion set of the present invention and a drug solution injecting apparatus using the same will be described below with reference to Examples. 1 is an explanatory view of an embodiment of the infusion set of the present invention, and FIG. 2 is an enlarged cross-sectional view of a balloon portion when the balloon of FIG. 1 is filled with a drug solution,
FIG. 3 is an explanatory view of the vicinity of the flow rate control unit in which a metering valve is arranged on the drug solution upstream side tube of the flow rate control unit, and FIG. 4 is an enlarged cross-sectional view of the balloon section of the drug solution injection device using the infusion set of the present invention. Figure,
FIG. 5 is an enlarged cross-sectional view of a balloon portion of a drug solution injector showing another embodiment of the drug solution injector using the infusion set of the present invention, and FIG. 6 is a drug solution described in JP-A-4-67873. FIG. 7 is an overall explanatory view of the injection device, and FIG. 7 is an enlarged cross-sectional view showing a state when the balloon of the housing shown in FIG. 6 is filled with a chemical solution.

【0008】図中、aはバル−ン部、bは薬液流通チュ
−ブ部、1はバル−ン、2はハウジング、3は薬液流出
口、4は薬液流入口、5は流量制御部、6は破断部材、
7は薬液流通チュ−ブ、8は接続具、9はバネ、10は定
量弁、11は開閉具、12および60は押圧部材、13はエア−
バッグ、14は三方活栓、37はフイルタ−、30はオリフイ
ス体、31は弁孔、32は筒状体、33は栓体、34は雌型螺子
部、35は雄型螺子部、36はキャップ体を示す。
In the drawing, a is a balloon portion, b is a chemical liquid flow tube portion, 1 is a balloon, 2 is a housing, 3 is a chemical liquid outlet, 4 is a chemical liquid inlet, 5 is a flow rate control portion, 6 is a breaking member,
7 is a chemical flow tube, 8 is a connecting tool, 9 is a spring, 10 is a metering valve, 11 is an opening / closing tool, 12 and 60 are pressing members, and 13 is air.
Bag, 14 is a three-way stopcock, 37 is a filter, 30 is an orifice body, 31 is a valve hole, 32 is a cylindrical body, 33 is a plug body, 34 is a female screw part, 35 is a male screw part, and 36 is a cap. Show the body.

【0009】図1は本発明の輸液セットの一実施例の説
明図であって、輸液セットはバル−ン部aと薬液流通チ
ュ−ブbとから構成されている。バル−ン部aは図2に
示すように薬液が収容されて加圧状態になった扁平形状
のバル−ン1の相対する辺に、夫々薬液流出口3と薬液
流入口4とが形成されている。薬液流入口4は内腔にゴ
ム状弾性体からなる薬液流入用栓体15が設けられてな
り、薬液を収納した注射器の穿刺針で刺通して薬液をバ
ル−ン1内に注入させる。薬液流入用栓体15としては、
シリコンゴム、ブチルゴム等の合成ゴム、天然ゴム等が
挙げられ、穿刺針の耐刺通性がよく、加圧状態のバル−
ン内の薬液の漏洩を防止するものがよい。図1および図
2では扁平形状のバル−ン1を使用しているが、一端が
閉じられた円筒状または球状の形状をしていてもよい。
円筒状のバル−ンでは半径方向とともに長手方向にも膨
張しうる構造になっている。バル−ン1は、患者への薬
液注入量、注入時間などに応じて種々の大きさ、肉厚の
ものを用いることができ、本発明においては特に限定さ
れるものでない。
FIG. 1 is an explanatory view of an embodiment of an infusion solution set of the present invention, which is composed of a balloon portion a and a liquid medicine distribution tube b. As shown in FIG. 2, the balun portion a has a liquid medicine outlet 3 and a liquid medicine inlet 4 formed on opposite sides of a flat shaped balloon 1 in which the liquid medicine is contained and is in a pressurized state. ing. The medicinal solution inlet 4 is provided with a medicinal solution inflow stopper 15 made of a rubber-like elastic material in its inner cavity, and the medicinal solution is injected into the balloon 1 by being pierced by a puncture needle of a syringe containing the medicinal solution. As the chemical liquid inflow plug 15,
Synthetic rubber such as silicone rubber and butyl rubber, natural rubber and the like can be mentioned. The puncture needle has good puncture resistance, and is a bar under pressure.
It is better to prevent the leakage of chemicals in the tank. Although the flat balloon 1 is used in FIGS. 1 and 2, it may have a cylindrical or spherical shape with one end closed.
The cylindrical balloon has a structure capable of expanding not only in the radial direction but also in the longitudinal direction. The balloon 1 can be used in various sizes and wall thicknesses according to the amount of drug solution to be injected into a patient, the time of injection, etc., and is not particularly limited in the present invention.

【0010】薬液流出口3は薬液流入口4が設置された
バッグの辺と相対する位置に設置されるのが好ましく、
可撓性チュ−ブ16からなりたっており、バル−ン1の縁
部と接着剤またはヒ−トシ−ルで接着されている。可撓
性チュ−ブ16内には、脆弱箇所17を有する剛直な破断部
材6が挿入されており、バル−ン1内の薬液が薬液流通
チュ−ブ7へ流出するのを防止している。破断部材6
は、例えば図2に示すように、中空の円筒部18、脆弱箇
所17および少なくとも2の長手方向の溝を有する円柱部
19からなっている。円柱部19の外径は可撓性チュ−ブ16
の内径より小さく、薬液が円柱部19の外壁と可撓性チュ
−ブ16の内壁との隙間から流れるようになっている。バ
ル−ン内の薬液は円筒部18まで流入しているが、脆弱箇
所17を介して円筒部18の内腔を閉鎖している円柱部19に
よって薬液の流れは閉鎖されている。破断部材6を破断
するには、人手で可撓性チュ−ブ16の外側から脆弱箇所
17を折り曲げて、円柱部19を円筒部18から引き離す。円
柱部19は可撓性チュ−ブ16の内腔に内挿されている薬液
流通チュ−ブ7の基端20で停止する。円柱部19の外壁に
は途中から少なくとも2の長手方向に延びた溝が形成さ
れているので、薬液はそれらの溝から薬液流通チュ−ブ
7へ流出する。図2では破断部材6で開閉具11を説明し
たが、開閉具11としては、図5に示す三方活栓14も使用
することができる。
The chemical liquid outlet 3 is preferably installed at a position facing the side of the bag in which the chemical liquid inlet 4 is installed,
It consists of a flexible tube 16 which is glued or glued to the edges of the balloon 1. A rigid breaking member 6 having a fragile portion 17 is inserted into the flexible tube 16 to prevent the chemical solution in the balloon 1 from flowing out to the chemical solution circulation tube 7. . Breaking member 6
Is, for example, as shown in FIG. 2, a cylindrical portion having a hollow cylindrical portion 18, a weakened portion 17 and at least two longitudinal grooves.
It consists of 19. The outer diameter of the cylindrical portion 19 is the flexible tube 16
The inner diameter of the flexible tube 16 is smaller than the inner diameter of the inner wall of the flexible tube 16, and the medicinal solution flows through the gap between the outer wall of the cylindrical portion 19 and the inner wall of the flexible tube 16. The chemical liquid in the balloon has flown into the cylindrical portion 18, but the flow of the chemical liquid is closed by the column portion 19 that closes the inner cavity of the cylindrical portion 18 via the weakened portion 17. In order to break the breaking member 6, a fragile portion is manually pressed from the outside of the flexible tube 16.
17 is bent, and the cylindrical portion 19 is separated from the cylindrical portion 18. The column portion 19 stops at the base end 20 of the drug solution flow tube 7 inserted in the inner cavity of the flexible tube 16. Since at least two grooves extending in the longitudinal direction are formed in the outer wall of the columnar portion 19 from the middle, the chemical liquid flows out to the chemical liquid flow tube 7 from these grooves. Although the opening / closing tool 11 is described with the breaking member 6 in FIG. 2, the three-way stopcock 14 shown in FIG. 5 can also be used as the opening / closing tool 11.

【0011】バル−ン1の材料としては弾性ゴムまたは
熱可塑性樹脂が挙げられる。弾性ゴムとしてはシリコ−
ンゴム、ブチルゴム、アクリロニトリルブタジェンゴ
ム、ブタジェンゴム、イソプレンゴム、ウレタンゴム、
スチレンブタジェンゴム、ペルプレン、クレイトンゴム
などの弾性重合体または天然ゴム、これらの重合体混合
物、またはこれらの物質の添加剤を除去したのち人体に
無害の酸化防止剤を添加した加工物質、またはラミネ−
ト等が挙げられる。また、熱可塑性樹脂としては、ポリ
エチレン、ポリプロピレン、ポリ塩化ビニル、ポリエス
テル、ポリアミド等の未延伸、1軸延伸または2軸延伸
フイルムが挙げられる。
Examples of the material of the balloon 1 include elastic rubber and thermoplastic resin. Silicone as elastic rubber
Rubber, butyl rubber, acrylonitrile butadiene rubber, butadiene rubber, isoprene rubber, urethane rubber,
Elastic polymers or natural rubbers such as styrene butadiene rubber, perprene, and Kraton rubber, mixtures of these polymers, or processed substances obtained by removing additives of these substances and then adding harmless antioxidants to the human body, or laminae. −
And the like. Examples of the thermoplastic resin include unstretched, uniaxially stretched or biaxially stretched films of polyethylene, polypropylene, polyvinyl chloride, polyester, polyamide and the like.

【0012】図1において、薬液流通チュ−ブ部bはバ
ル−ン1の薬液流出口3または薬液流通チュ−ブ7の基
端に設置された開閉具11、薬液量を制御するための流量
制御部5、薬液流通チュ−ブ7および接続具8とで構成
されており、バル−ン1から流出した薬液は流量制御部
5を経て接続具8に接続された穿刺針またはカテ−テル
から人体に注入される。流量制御部5は薬液の流量を制
御する箇所であり、例えば図3に示すような内径10〜 5
00μの微細内径のパイプを設置すると、バル−ン1内の
薬液の流出速度が遅くなり、人体への薬液注入時間を長
くすることができる。パイプの長さは1cm以上で外径は
内径の5〜 500倍の大きさである。パイプの長さが30mm
を越えると、図3に示すような捲縮構造をした微細内径
パイプ25を収納したケ−ス26を使用すると薬液流通チュ
−ブ7の長さが短くなって好ましい。流量制御部5とし
ては、本出願人が既に出願した特開平2-11160 号公報あ
るいは特開平3-140163号公報に記載された金属製パイ
プ、合成樹脂製パイプ、ガラス製パイプなども用いられ
ることができる。
In FIG. 1, a chemical liquid flow tube portion b is an opening / closing device 11 installed at the chemical liquid flow outlet 3 of the balloon 1 or the proximal end of the chemical liquid flow tube 7, and a flow rate for controlling the chemical liquid amount. It is composed of a control unit 5, a drug solution distribution tube 7 and a connector 8. The drug solution flowing out from the balloon 1 is discharged from a puncture needle or a catheter connected to the connector 8 via the flow rate controller 5. Injected into the human body. The flow rate control part 5 is a part for controlling the flow rate of the chemical liquid, and has an inner diameter of 10 to 5 as shown in FIG. 3, for example.
If a pipe having a fine inner diameter of 00 μ is installed, the outflow rate of the drug solution in the balloon 1 is slowed down, and the time for injecting the drug solution into the human body can be lengthened. The length of the pipe is more than 1 cm and the outer diameter is 5 to 500 times larger than the inner diameter. Pipe length is 30mm
If it exceeds the above range, it is preferable to use the case 26 accommodating the fine inner diameter pipe 25 having a crimped structure as shown in FIG. 3 because the length of the chemical liquid circulation tube 7 becomes short. As the flow rate control unit 5, a metal pipe, a synthetic resin pipe, a glass pipe, etc. described in Japanese Patent Application Laid-Open No. 2-11160 or Japanese Patent Application Laid-Open No. 3-140163, which the applicant of the present application has already applied, may also be used. You can

【0013】流量制御部5は薬液流通チュ−ブ7の任意
の位置に設置されうるが、接続具8から離れた位置に設
置されるのが操作上好ましい。流量制御部5からその下
流に位置する接続具8までの薬液下流側チュ−ブdは、
その内径が流量制御部5からその上流に位置する薬液流
出口3方向へ延びた薬液上流側チュ−ブcの内径に比較
して小さい。薬液下流側チュ−ブdの内径は薬液上流側
チュ−ブcの内径に対して15%〜85%、好ましくは30%
〜70%である。薬液上流側チュ−ブcと薬液下流側チュ
−ブdの内径の比率は、薬液下流側チュ−ブdの長さに
よっても異なる。開閉具11と流量制御部5との間には、
バル−ン1内の薬液に含有されている微小物質を除去す
るためのフイルタ−が設けられていてもよい。フイルタ
−は流量制御部5の先端部に設置されるのが好ましく、
繊維状物、焼結物等が使用される。薬液流通チュ−ブ7
としては、軟質ポリ塩化ビニル、ポリプロピレン、ポリ
エステルなどが挙げられ、その先端にはルア−テ−パ−
状の接続具8が設けられ、接続具8を介して静脈針やP
SVセット、カテ−テルなどが接続される。接続具8に
は静脈圧などにより薬液が逆流するのを防止するための
逆止弁(表示せず)を装備してもよい。
The flow rate control unit 5 can be installed at any position of the chemical liquid flow tube 7, but it is preferable in operation to be installed at a position away from the connector 8. The chemical solution downstream side tube d from the flow rate control section 5 to the connecting tool 8 located downstream thereof is
The inner diameter is smaller than the inner diameter of the chemical liquid upstream tube c extending from the flow rate control unit 5 toward the chemical liquid outlet 3 located upstream thereof. The inner diameter of the chemical solution downstream tube d is 15% to 85%, preferably 30%, of the inner diameter of the chemical solution upstream tube c.
~ 70%. The ratio of the inner diameters of the chemical liquid upstream tube c and the chemical liquid downstream tube d also differs depending on the length of the chemical liquid downstream tube d. Between the opening / closing tool 11 and the flow rate control unit 5,
A filter for removing minute substances contained in the chemical liquid in the balloon 1 may be provided. The filter is preferably installed at the tip of the flow rate control unit 5,
A fibrous material, a sintered material or the like is used. Liquid distribution tube 7
Examples thereof include soft polyvinyl chloride, polypropylene, polyester and the like, and the luer taper is provided at the tip thereof.
-Like connection tool 8 is provided, and a venous needle or P is connected through the connection tool 8.
An SV set, a catheter, etc. are connected. The connector 8 may be equipped with a check valve (not shown) for preventing the chemical liquid from flowing back due to venous pressure or the like.

【0014】図3は流量制御部5の薬液上流側に定量弁
10を設けた流量制御部5付近の説明図である。流量制御
部5の薬液上流側入口に定量弁10を設けることによっ
て、流量制御部5に流入する薬液量をほぼ一定にするこ
とができるので、更に正確に流量を制御することができ
る。図3の定量弁10は一例であるが、変形可能なゴム状
弾性体からなるオリフイス体30を固着する筒状体32の薬
液上流側に栓体33、薬液下流側にキャップ体36が装着さ
れており、オリフイス体30の弁孔31の前後で、その同軸
方向に薬液チュ−ブ38、39、薬液通路40、41が配設され
た構造をしている。オリフイス体30は薬液上流側から薬
液下流側に通じる弁孔31を有し、該弁孔31は弁孔入口か
ら入った途中で内径が最小になり、該最小位置から薬液
下流側に行くに従って次第に内径が大きくなった形状を
している。弁孔31の内径は所望する薬液流出速度によっ
て随意変更できる。オリフイス体30は筒状体32の内壁に
固着される。筒状体32の薬液流入側の内壁には雌型螺子
部34が形成され、栓体33の雄型螺子部35と螺合し、栓体
33を回転させることによってオリフイス体30を押圧し、
弁孔31の内径を調整する。弁孔31と薬液上流側チュ−ブ
cとの間には、バル−ン1内の薬液に含有されている微
小物質を除去するためのフイルタ−37が設けられていて
もよい。フイルタ−37は薬液上流側チュ−ブcの先端部
に設置されるのが好ましい。
FIG. 3 shows a metering valve on the upstream side of the liquid chemical in the flow control unit 5.
FIG. 3 is an explanatory diagram of the vicinity of a flow rate control unit 5 provided with 10. By providing the metering valve 10 at the chemical solution upstream side inlet of the flow rate control section 5, the quantity of the chemical solution flowing into the flow rate control section 5 can be made substantially constant, so that the flow rate can be controlled more accurately. The metering valve 10 of FIG. 3 is an example, but a plug body 33 is mounted on the upstream side of the chemical liquid and a cap body 36 is mounted on the downstream side of the chemical liquid of a cylindrical body 32 to which an orifice body 30 made of a deformable rubber-like elastic body is fixed. In this structure, the chemical liquid tubes 38, 39 and the chemical liquid passages 40, 41 are arranged in the axial direction in front of and behind the valve hole 31 of the orifice body 30. The orifice body 30 has a valve hole 31 communicating from the chemical solution upstream side to the chemical solution downstream side, the inner diameter of the valve hole 31 becomes the minimum on the way from the valve hole inlet, and gradually goes from the minimum position to the chemical solution downstream side. It has a shape with a large inner diameter. The inner diameter of the valve hole 31 can be arbitrarily changed according to the desired chemical solution outflow rate. The orifice body 30 is fixed to the inner wall of the tubular body 32. A female screw portion 34 is formed on the inner wall of the tubular body 32 on the chemical liquid inflow side, and is screwed with a male screw portion 35 of the stopper body 33 to form a stopper body.
Pressing the orifice body 30 by rotating 33,
The inner diameter of the valve hole 31 is adjusted. A filter 37 for removing minute substances contained in the chemical liquid in the balloon 1 may be provided between the valve hole 31 and the chemical liquid upstream tube c. The filter 37 is preferably installed at the tip of the tube c upstream of the chemical solution.

【0015】栓体33はオリフイス体30の弁孔31の入口と
連通するための薬液上流側通路40と、該薬液上流側通路
40と連結した薬液上流側チュ−ブcが装着されており、
栓体33の先端部はオリフイス体30と接し、薬液上流側通
路40の出口とオリフイス体30の弁孔31の入口とは同軸方
向に連通している。栓体33の先端側面部には筒状体32の
雌型螺子部34と螺合する雄型螺子部35が形成されてお
り、栓体33を回転させることによって雄型螺子部35が雌
型螺子部34を移動してオリフイス体30の弁孔31の内径の
大きさを調整し薬液の流出速度を調節する。キャップ体
36はオリフイス体30の弁孔31の出口と連通するための薬
液下流側通路41と、該薬液下流側通路41と連結した薬液
下流側チュ−ブdが配設されている。キャップ体36の一
端はオリフイス体30と接し、筒状体32の内腔に嵌着さ
れ、薬液下流側通路41の入口とオリフイス体30の弁孔31
の出口とは同軸方向に連通している。
The stopper 33 is a chemical liquid upstream passage 40 for communicating with the inlet of the valve hole 31 of the orifice body 30, and the chemical liquid upstream passage 40.
A chemical solution upstream tube c connected to 40 is attached,
The tip of the stopper 33 is in contact with the orifice body 30, and the outlet of the chemical solution upstream passage 40 and the inlet of the valve hole 31 of the orifice body 30 are coaxially communicated with each other. A male screw portion 35 that is screwed with the female screw portion 34 of the tubular body 32 is formed on the tip side surface portion of the plug body 33, and by rotating the plug body 33, the male screw portion 35 becomes a female screw portion. The screw portion (34) is moved to adjust the inner diameter of the valve hole (31) of the orifice body (30) to adjust the outflow rate of the drug solution. Cap body
36 is provided with a chemical liquid downstream side passage 41 for communicating with the outlet of the valve hole 31 of the orifice body 30, and a chemical liquid downstream side tube d connected to the chemical liquid downstream side passage 41. One end of the cap body 36 is in contact with the orifice body 30 and is fitted into the inner cavity of the tubular body 32. The inlet of the chemical liquid downstream side passage 41 and the valve hole 31 of the orifice body 30.
Is coaxially communicated with the outlet.

【0016】図3の定量弁10において、オリフイス体30
のほぼ中央部には弁孔31が形成され、栓体33を回転させ
ることによって栓体33の先端はゴム状弾性体からなるオ
リフイス体30の環状足部を押圧し、弁孔31の内径が僅か
に変化して薬液流出速度が設定される。弁孔31は弁孔入
口から入った途中で内径が最小になり、該最小位置から
薬液下流側に行くに従って次第に内径が大きくなった形
状をしている。かかる状態で薬液上流側チュ−ブcから
薬液上流側通路40を経て供給された薬液は、オリフイス
体31の入口に形成された凹状空間部を経て弁孔31の入口
に達し、その入口に与える圧力によって弁孔31の内径の
最小位置が微妙に変化する。その結果、常時弁孔31の出
口から流出する薬液の圧力はほぼ一定に保たれる。
In the metering valve 10 of FIG.
A valve hole 31 is formed in the substantially central portion of the valve body, and by rotating the stopper body 33, the tip of the stopper body 33 presses the annular foot portion of the orifice body 30 made of a rubber-like elastic body, and the inner diameter of the valve hole 31 becomes smaller. A slight change is made to set the chemical solution outflow rate. The valve hole 31 has a shape in which the inner diameter becomes the minimum on the way from the inlet of the valve hole, and the inner diameter gradually increases from the minimum position toward the downstream side of the chemical solution. In this state, the chemical liquid supplied from the chemical liquid upstream tube c through the chemical liquid upstream passage 40 reaches the inlet of the valve hole 31 through the concave space formed at the inlet of the orifice body 31, and is applied to the inlet. The minimum position of the inner diameter of the valve hole 31 slightly changes due to the pressure. As a result, the pressure of the chemical liquid that constantly flows out from the outlet of the valve hole 31 is kept substantially constant.

【0017】オリフイス体30は変形可能なゴム状弾性体
からなる。ゴム状弾性体の材料としてはスチレン・ブタ
ジエンゴム、イソプレンゴム、アクリロニトリル・ブタ
ジエンゴム、ブタジエンゴム、オレフイン系ゴム、フッ
ソ系ゴム、シリコ−ンゴム、ウレタンゴム、クレイトン
ゴム、ペルプレンなどの合成ゴム、天然ゴムなどが挙げ
られる。弾性体の硬度はJIS-A 型によるスプリング式硬
さ試験機で測定した硬度が25〜70度、好ましくは35〜60
度である。硬度が25度未満であると、オリフイス体30が
薬液の圧力によって簡単に変形しすぎる傾向があり、弁
孔31の内径の調整が困難であり、硬度が70度を越えると
僅かの薬液流出圧力の変化に対してオリフイス体30が反
応せず、弁孔31の内径が変化しない傾向がある。弁孔31
の内径は所望する薬液流出速度によって任意に変更可能
であるが、通常は 100〜1000μが好ましい。
The orifice body 30 is made of a deformable rubber-like elastic body. Examples of rubber-like elastic materials include styrene / butadiene rubber, isoprene rubber, acrylonitrile / butadiene rubber, butadiene rubber, olefin rubber, fluorine rubber, synthetic rubber such as silicone rubber, urethane rubber, kraton rubber, and perprene, and natural rubber. And so on. The hardness of the elastic body is 25 to 70 degrees, preferably 35 to 60, measured by a JIS-A type spring hardness tester.
It is degree. If the hardness is less than 25 degrees, the orifice body 30 tends to be easily deformed by the pressure of the chemical solution, making it difficult to adjust the inner diameter of the valve hole 31. There is a tendency that the orifice body 30 does not react to the change of the above and the inner diameter of the valve hole 31 does not change. Valve hole 31
The inner diameter of can be arbitrarily changed according to the desired outflow rate of the drug solution, but is usually preferably 100 to 1000 μm.

【0018】図4は本発明輸液セットを使用した薬液注
入器具の実施例で、バル−ン部の拡大断面図である。ハ
ウジング2は上蓋部55と下蓋部56とからなり、下蓋部56
に輸液セットのバル−ン1を設置し、下蓋部56の側壁に
形成された挿入孔57に可撓性チュ−ブ16が挿入されて薬
液流通チュ−ブ部bが下蓋部56の外部に配置される。薬
液を人体に注入するときには、上蓋部55と下蓋部56とは
それぞれの開口に設けられた雄ネジと雌ネジとで螺合し
て閉じられた状態になっている。上蓋部55にはバネ9と
バル−ン1を押圧するための押圧部材12とが収容されて
いる。該バネ9の基端は上蓋部55の内壁の係止部62で固
定され、バネ9の他端は押圧部材12の内壁の係止部63で
固定されている。図4の薬液注入器具の使用方法は、バ
ル−ン1の薬液注入口3から注射針でバル−ン1内に必
要量の薬液を流入させる。次いで下蓋部56にバル−ン1
を設置し、上蓋部55と下蓋部56とを螺合することによっ
て、上蓋部55と下蓋部56とが閉じられ、バネ9が押圧部
材12を介して薬液が充填されたバル−ン1を押圧する。
引続き、破断部材6を破断することによって薬液流通チ
ュ−ブ7内に薬液が流出し、流量制御部5および接続具
8を経て人体に薬液が注入される。図4においては、バ
ネ9としてコイルバネが使用されているが、他に引張ま
たは押す力が一定である定荷重バネも使用することがで
きる。
FIG. 4 is an enlarged cross-sectional view of the balloon part of an embodiment of the drug solution injecting device using the infusion set of the present invention. The housing 2 includes an upper lid portion 55 and a lower lid portion 56, and the lower lid portion 56
The balloon 1 of the infusion set is installed in the container, and the flexible tube 16 is inserted into the insertion hole 57 formed in the side wall of the lower lid portion 56 so that the drug solution distribution tube portion b is located in the lower lid portion 56. It is placed outside. When injecting the drug solution into the human body, the upper lid portion 55 and the lower lid portion 56 are in a closed state by being screwed with a male screw and a female screw provided in each opening. A spring 9 and a pressing member 12 for pressing the balloon 1 are housed in the upper lid portion 55. The base end of the spring 9 is fixed by a locking portion 62 on the inner wall of the upper lid 55, and the other end of the spring 9 is fixed by a locking portion 63 on the inner wall of the pressing member 12. In the method of using the drug solution injector of FIG. 4, a required amount of drug solution is made to flow into the ball 1 from the drug solution inlet 3 of the balloon 1 with an injection needle. Next, attach the ball 1 to the lower lid 56.
Is installed, and the upper lid portion 55 and the lower lid portion 56 are screwed together to close the upper lid portion 55 and the lower lid portion 56, and the spring 9 is filled with the chemical liquid via the pressing member 12. Press 1.
Subsequently, by breaking the breaking member 6, the chemical liquid flows out into the chemical liquid flow tube 7, and the chemical liquid is injected into the human body through the flow rate control unit 5 and the connector 8. Although a coil spring is used as the spring 9 in FIG. 4, a constant force spring having a constant pulling or pushing force can also be used.

【0019】図5は本発明輸液セットを使用した薬液注
入器具の他の実施例で、バル−ン部の拡大断面図であ
る。ハウジング2は上蓋部65と下蓋部66とからなり、下
蓋部66には輸液セットのバル−ン1を設置し、下蓋部66
の側壁に形成された挿入孔67に可撓性チュ−ブ16が挿入
され、該可撓性チュ−ブ16の反対側の端部には三方活栓
14が設置され、引続き薬液流通チュ−ブ7が配置されて
いる。上蓋部65には、圧縮空気を内部に充満させること
によって、体積が膨張した扁平形状のエア−バッグ13と
バル−ン1を押圧するための押圧部材68とが収容されて
いる。押圧部材68をなくして、エア−バッグ13で直接バ
ル−ン1を押圧してもよい。エア−バッグ13は開口69か
ら延びた空気チュ−ブ70の先端に設けられた空気通気孔
71を有する中空のゴム球72と、空気チュ−ブ70の途中に
エア−バッグ64内の空気が流出するのを防止するための
クランプ73とから構成されている。また、必要により、
空気チュ−ブ70の途中に圧力計、定圧弁を設けてもよ
い。上蓋部65の側壁には、空気チュ−ブ70を挿入するた
めの挿入口74が形成されている。図5の薬液注入器具の
使用方法は、バル−ン1の薬液注入口3から注射針でバ
ル−ン1内に必要量の薬液を流入させる。次いで下蓋部
66にバル−ン1を設置し、上蓋部65と下蓋部66とを螺合
することによって、上蓋部65と下蓋部66とが閉じられ
る。引続き、エア−バッグ13にゴム球72から圧縮空気を
流入させ、クランプ73で空気チュ−ブ70を閉鎖すること
によって、押圧部材68を介して薬液が充填されたバル−
ン1を押圧する。更に、可撓性チュ−ブ16に設置された
三方活栓14を回転させることによって、薬液が薬液流通
チュ−ブ7内に流出し、流量制御部5および接続具8を
経て人体に薬液が注入される。図5においては、扁平形
状のエア−バッグ13を使用したが、球状、一端が閉じた
円筒状のエア−バッグでもよい。
FIG. 5 is an enlarged cross-sectional view of the balloon part of another embodiment of the drug solution injector using the infusion set of the present invention. The housing 2 is composed of an upper lid portion 65 and a lower lid portion 66. The infusion set balloon 1 is installed in the lower lid portion 66, and the lower lid portion 66 is provided.
A flexible tube 16 is inserted into an insertion hole 67 formed in a side wall of the flexible tube 16, and a three-way stopcock is provided at an end portion on the opposite side of the flexible tube 16.
14 is installed, and the chemical liquid distribution tube 7 is continuously arranged. The upper lid 65 accommodates a flat air bag 13 whose volume is expanded by filling the inside with compressed air and a pressing member 68 for pressing the balloon 1. The pressing member 68 may be omitted and the balloon 1 may be directly pressed by the airbag 13. The air bag 13 is an air vent hole provided at the tip of an air tube 70 extending from the opening 69.
It is composed of a hollow rubber ball 72 having 71 and a clamp 73 for preventing the air in the air bag 64 from flowing out in the middle of the air tube 70. Also, if necessary,
A pressure gauge and a constant pressure valve may be provided in the middle of the air tube 70. An insertion port 74 for inserting the air tube 70 is formed on the side wall of the upper lid portion 65. In the method of using the drug solution injector of FIG. 5, a required amount of drug solution is made to flow into the ball 1 from the drug solution inlet 3 of the ball 1 with an injection needle. Then the lower lid
The upper lid 65 and the lower lid 66 are closed by installing the balloon 1 in 66 and screwing the upper lid 65 and the lower lid 66 together. Subsequently, compressed air is allowed to flow into the air bag 13 from the rubber ball 72, and the air tube 70 is closed by the clamp 73, so that the valve filled with the chemical solution via the pressing member 68.
Press button 1. Further, by rotating the three-way stopcock 14 installed in the flexible tube 16, the drug solution flows out into the drug solution flow tube 7, and the drug solution is injected into the human body through the flow rate control unit 5 and the connector 8. To be done. Although the flat air bag 13 is used in FIG. 5, it may be a spherical air bag or a cylindrical air bag with one end closed.

【0020】[0020]

【発明の効果】本発明輸液セットは薬液をバル−ン内に
充填して膨張したバル−ンの収縮力を利用するので、輸
液セットを人体に携帯し歩行しながらでも人体に薬液を
注入することができる。また、本発明輸液セットを使用
した薬液注入器具は薬液を充填したバル−ンの外側か
ら、該バル−ンの収縮力より大きい圧縮機構でバル−ン
を圧縮することによってバル−ン内の薬液を患者に注入
する機構であるので、ハウジング内のバル−ンの操作機
構を従来の薬液注入器具より簡略化するとともに、バル
−ン内の薬液を殆ど最後まで一定流出速度で患者に注入
することができる。更に、流量制御部の薬液上流側入口
に定量弁を設置することによって流量制御部に流入する
薬液量をほぼ一定にすることができ、更に正確に薬液量
を制御することができ、患者へ薬液を長時間一定速度で
注入することができる。
INDUSTRIAL APPLICABILITY The infusion set of the present invention utilizes the contraction force of the balloon which is filled with the medicinal solution in the balloon and inflates the medicinal solution into the human body while carrying the infusion set on the human body and walking. be able to. Further, a drug solution injecting device using the infusion set of the present invention is a drug solution in a balloon, which is obtained by compressing the balloon from the outside of the balloon filled with the drug solution with a compression mechanism larger than the contraction force of the balloon. Since it is a mechanism for injecting into the patient, the operation mechanism of the balloon in the housing is simplified as compared with the conventional drug solution injecting device, and the drug solution in the balloon is injected into the patient at a constant outflow rate almost to the end. You can Further, by installing a metering valve at the drug solution upstream side inlet of the flow rate control unit, the amount of the drug solution flowing into the flow rate control unit can be made substantially constant, and the drug solution amount can be controlled more accurately and the drug solution can be delivered to the patient. Can be infused at a constant rate for a long time.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の輸液セットの一実施例の説明図。FIG. 1 is an explanatory view of an embodiment of an infusion set of the present invention.

【図2】図1のバル−ンに薬液を充填したときのバル−
ン部の拡大断面図。
FIG. 2 is a balloon when the balloon of FIG. 1 is filled with a chemical solution.
FIG.

【図3】流量制御部の薬液上流側チュ−ブに定量弁を配
設した流量制御部付近の説明図。
FIG. 3 is an explanatory view of the vicinity of a flow rate control unit in which a metering valve is arranged in a tube on the upstream side of the chemical liquid of the flow rate control unit.

【図4】本発明の輸液セットを使用した薬液注入器具の
バル−ン部の拡大断面図。
FIG. 4 is an enlarged cross-sectional view of a balloon part of a drug solution injector using the infusion set of the present invention.

【図5】本発明の輸液セットを使用した薬液注入器具の
他の実施例を示す薬液注入器具のバル−ン部の拡大断面
図。
FIG. 5 is an enlarged cross-sectional view of the balloon portion of the drug solution injector showing another embodiment of the drug solution injector using the infusion set of the present invention.

【図6】特開平4-67873号公報に記載されている薬液注
入器具の全体説明図。
FIG. 6 is an overall explanatory view of a drug solution injecting device described in JP-A-4-67873.

【図7】図6に示すハウジングのバル−ンに薬液を充填
した時の状態を示す拡大断面図。
FIG. 7 is an enlarged cross-sectional view showing a state when the balloon of the housing shown in FIG. 6 is filled with a chemical liquid.

【符号の説明】[Explanation of symbols]

a バル−ン部 b 薬液流通チュ−ブ部 1 バル−ン 2 ハウジング 3 薬液流出口 4 薬液流入口 5 流量制御部 6 破断部材 7 薬液流通チュ−ブ 8 接続具 9 バネ 10 定量弁 11 開閉具 12、68 押圧部材 13 エア−バッグ 14 三方活栓 a Balloon portion b Chemical liquid flow tube portion 1 Balloon 2 Housing 3 Chemical liquid flow outlet 4 Chemical liquid flow inlet 5 Flow control unit 6 Breaking member 7 Chemical liquid flow tube 8 Connector 9 Spring 10 Metering valve 11 Opening / closing device 12, 68 Pressing member 13 Air bag 14 Three-way stopcock

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 加圧状態で薬液を貯蔵し、かつ薬液を流
入させるための薬液流入口と薬液を流出させるための薬
液流出口とを有するバル−ンと、該薬液流出口から延び
た薬液流通チュ−ブとからなる輸液セットにおいて、前
記薬液流通チュ−ブに薬液を流通または閉止するための
開閉具、薬液注入速度を制御するための流量制御部、お
よび注射針またはカテ−テルと接続するための接続具が
設けられてなる輸液セット。
1. A balloon having a chemical solution inlet for storing the chemical solution under pressure and for allowing the chemical solution to flow in and a chemical solution outlet for letting the chemical solution flow out, and a chemical solution extending from the chemical solution outlet. In an infusion set comprising a distribution tube, an opening / closing tool for circulating or closing the solution in the solution distribution tube, a flow rate control unit for controlling the solution injection rate, and an injection needle or a catheter. An infusion set provided with a connecting tool for doing.
【請求項2】 開閉具が破断部材または三方活栓からな
る請求項1記載の輸液セット。
2. The infusion set according to claim 1, wherein the opening / closing tool is a breaking member or a three-way stopcock.
【請求項3】 バル−ン材料が弾性ゴムまたは熱可塑性
樹脂からなる請求項1または2記載の輸液セット。
3. The infusion set according to claim 1, wherein the balloon material is made of elastic rubber or thermoplastic resin.
【請求項4】 流量制御部の薬液上流側に定量弁が設け
られてなる請求項1〜3記載のいずれかである輸液セッ
ト。
4. The infusion set according to claim 1, wherein a metering valve is provided on the upstream side of the liquid medicine in the flow rate control unit.
【請求項5】 定量弁が内径が変形可能な弁孔を有する
ゴム状弾性体からなるオリフイス体と、該弁孔の内径を
調整するための調整手段とからなる請求項4記載の輸液
セット。
5. The infusion set according to claim 4, wherein the metering valve comprises an orifice body made of a rubber-like elastic body having a valve hole whose inner diameter is deformable, and an adjusting means for adjusting the inner diameter of the valve hole.
【請求項6】 バル−ンが扁平形状をしてなる請求項1
〜5のいずれかに記載の輸液セット。
6. The ball has a flat shape.
The infusion set according to any one of to 5.
【請求項7】 ハウジング内に輸液セットのバル−ン
と、薬液を充填したバル−ンの圧力より高い圧力で前記
バル−ンを加圧する加圧機構とが収容されてなる請求項
1〜6のいずれかに記載の薬液注入器具。
7. A housing for accommodating a balloon of an infusion set and a pressurizing mechanism for pressurizing the balloon at a pressure higher than the pressure of the balloon filled with the liquid medicine. The drug solution injector according to any one of 1.
【請求項8】 加圧機構がバネまたは加圧ガスを使用し
てなる請求項7記載の薬液注入器具。
8. The drug solution injector according to claim 7, wherein the pressurizing mechanism uses a spring or a pressurizing gas.
JP5179888A 1993-06-25 1993-06-25 Chemical injection device Expired - Fee Related JP2725557B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP5179888A JP2725557B2 (en) 1993-06-25 1993-06-25 Chemical injection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5179888A JP2725557B2 (en) 1993-06-25 1993-06-25 Chemical injection device

Publications (2)

Publication Number Publication Date
JPH07222798A true JPH07222798A (en) 1995-08-22
JP2725557B2 JP2725557B2 (en) 1998-03-11

Family

ID=16073657

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5179888A Expired - Fee Related JP2725557B2 (en) 1993-06-25 1993-06-25 Chemical injection device

Country Status (1)

Country Link
JP (1) JP2725557B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11169458A (en) * 1997-12-09 1999-06-29 Daiken Iki Kk Administration device
WO2000018452A1 (en) * 1998-09-28 2000-04-06 Tsukada Medical Research Co., Ltd. Portable, disposable charging pump equipped with variable flow rate device

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944269A (en) * 1982-09-02 1984-03-12 日機装株式会社 Apparatus for injecting drug
JPS61164564A (en) * 1985-01-10 1986-07-25 ジヨゼ・ア−ル・ナヴオト Automatic solution injector
JPS6249863A (en) * 1985-06-21 1987-03-04 アプライド バイオメデイカル コ−ポレ−シヨン Injection apparatus
JPS6470069A (en) * 1987-06-18 1989-03-15 Nissho Kk Balloon infuser
JPH0194859A (en) * 1987-10-05 1989-04-13 Nissho Corp Injector for continuous infusion of trace amount of fluid and its application method
JPH02102251U (en) * 1989-01-25 1990-08-14
JPH03133460A (en) * 1989-10-18 1991-06-06 Nissho Corp Balloon infuser
JPH03158169A (en) * 1989-11-06 1991-07-08 Cobe Lab Inc Fluid amount control device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944269A (en) * 1982-09-02 1984-03-12 日機装株式会社 Apparatus for injecting drug
JPS61164564A (en) * 1985-01-10 1986-07-25 ジヨゼ・ア−ル・ナヴオト Automatic solution injector
JPS6249863A (en) * 1985-06-21 1987-03-04 アプライド バイオメデイカル コ−ポレ−シヨン Injection apparatus
JPS6470069A (en) * 1987-06-18 1989-03-15 Nissho Kk Balloon infuser
JPH0194859A (en) * 1987-10-05 1989-04-13 Nissho Corp Injector for continuous infusion of trace amount of fluid and its application method
JPH02102251U (en) * 1989-01-25 1990-08-14
JPH03133460A (en) * 1989-10-18 1991-06-06 Nissho Corp Balloon infuser
JPH03158169A (en) * 1989-11-06 1991-07-08 Cobe Lab Inc Fluid amount control device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11169458A (en) * 1997-12-09 1999-06-29 Daiken Iki Kk Administration device
WO2000018452A1 (en) * 1998-09-28 2000-04-06 Tsukada Medical Research Co., Ltd. Portable, disposable charging pump equipped with variable flow rate device

Also Published As

Publication number Publication date
JP2725557B2 (en) 1998-03-11

Similar Documents

Publication Publication Date Title
KR960012362B1 (en) Liquid infusion device
KR101013538B1 (en) Controlled-volume infusion device
US5059182A (en) Portable infusion device
CA1165199A (en) Medical infusor
US7018360B2 (en) Flow restriction system and method for patient infusion device
US5318539A (en) Liquid feeding apparatus utilizing capillary tubing, and syringe driver
KR970005840B1 (en) Continuous drug solution injector equipped with balloon
WO1990014115A1 (en) Balloon-carrying instrument for use in continuously injecting medical fluid
JP4539382B2 (en) Patient controlled analgesia (PCA) device with continuous infusion and additional administration
JP4898183B2 (en) Chemical self-injection system
EP0327555B1 (en) Apparatus for feeding drugs
JPH07222798A (en) Transfusion set and medicinal liquid injecting device using the same
JP3102173B2 (en) Chemical injection device
JP3245841B2 (en) Chemical injection device
JP3120922B2 (en) Chemical injection device
JPH10113385A (en) Liquid medicine continuous injection device
CN211986537U (en) Infusion device
JP3586964B2 (en) Continuous injector
JP3152149B2 (en) Flow control device with priming mechanism
JPH0687898B2 (en) Balloon infusor
JP2552692B2 (en) Drug supply device
JP2637579B2 (en) Balloon infuser
JPH10248928A (en) Medical fluid supply jig and priming device
JP2598529B2 (en) Balloon infuser
JP2586275B2 (en) Chemical injection tool

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees